Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis-Reference-Cited by-同舟云学术

Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis

Published:2022-05 Issue: Volume:Volume 18 Page:603-617
ISSN:1178-203X
Container-title:Therapeutics and Clinical Risk Management
language:en
Short-container-title:TCRM

Author:

Lagier Jean-Christophe,Million Matthieu,Cortaredona Sébastien,Delorme Léa,Colson Philippe^ORCID,Fournier Pierre-Edouard,Brouqui Philippe,Raoult Didier,Parola Philippe^ORCID

Publisher

Informa UK Limited

Subject

Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine

Reference54 articles.

1. Johns Hopkins University. Coronavirus Resource Center. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available from: https://coronavirus.jhu.edu/map.html. Accessed January 17, 2022.

2. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

3. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

4. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect

5. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients;New Microbes and New Infections;2023-10

2. Efficacy and safety of in-hospital treatment of Covid-19 infection with low-dose hydroxychloroquine and azithromycin in hospitalized patients: A retrospective controlled cohort study;New Microbes and New Infections;2023-10

3. Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients;Medicina;2023-04-29

4. Early Treatment with Hydroxychloroquine and Azithromycin: A ‘Real-World’ Monocentric Retrospective Cohort Study of 30,423 COVID-19 Patients;2023-04-04

5. Perspective: repurposed Drugs for COVID-19;Archives of Medical Science;2022-08-30